The Cost Connection: Chronic Disease and Healthcare Services Utilization
As a founding member of the AF Stat coalition, StopAfib.org would like to invite you to attend the next AF Stat meeting. See the details below.
Wednesday, September 22, 2010
Webcast: 9:00 a.m. – 11:00 a.m. EST
RSVP Today
OVERVIEW
With the passage of the Patient Protection and Affordable Care Act, policymakers and medical professionals have begun to focus on the implementation of healthcare reform and what it means for the treatment of chronic illness. These complex illnesses have been shown to result in increased healthcare services utilization, a major driver of healthcare costs and area for quality improvement.
This forum will include a panel of leading healthcare experts who will discuss challenges, opportunities and priorities to lower the use of healthcare services related to chronic disease as part of health reform implementation. This forum will also feature new data from Avalere Health, analyzing the impact of one common chronic illness – atrial fibrillation (AFib) – as a driver of healthcare costs.
Date: Wednesday, September 22, 2010
Time: 9:00 a.m. – 11:00 a.m. EST
Webcast or Live at Reserve Officers Association Conference Center, One Constitution Avenue NE,Washington, DC 20002
RSVP: Jacqueline Karis at 202-609-6018 or via email at [email protected]
SPEAKERS
- Senator Bill Frist, MD, Former Senate Majority Leader and AF Stat Policy Advisor
- Jerry West, AFib Patient and NBA Hall of Famer
- Thomas A. Pearson, MD, MPH, PhD, Chair, National Forum for Heart Disease and Stroke Prevention
- Erin Sullivan, Vice President, Avalere Health
- Lisa Rockelli, Managing Editor, BNA’s Medicare Report
- Mark Stewart, MPH, Associate Director, American College of Cardiology
- Mary G. George, MD, MSPH, FACS, FAHA, Medical Officer, Centers for Disease Control and Prevention
Health Services Utilization and Medical Costs Among Medicare Atrial Fibrillation Patients was written by Avalere Health and funded by sanofi-aventis U.S. LLC, which is also the sponsor for AF Stat. Avalere Health maintained editorial control and the conclusions expressed in the report are those of the authors.
ABOUT AF STAT AND AFIB
AF Stat, an initiative sponsored by sanofi-aventis U.S. LLC, is a collaboration of healthcare leaders and organizations working to improve the health and well-being of people affected by AFib, a common, costly, progressive and often debilitating cardiovascular disease. The most common form of heart arrhythmia, AFib affects approximately 2.5 million Americans, and its prevalence is expected to increase as the U.S. population ages.1 AFib is associated with a fivefold increase in risk for stroke;2 worsens underlying cardiovascular disease;3 and doubles the risk of all-cause mortality.4 To learn more about AF Stat and AFib visit www.AFStat.com.
1 Go A. Prevalence of Atrial Fibrillation in Adults: National Implications for Rhythm Management and Stroke Prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA, May 9, 2001-Vol 285, No. 18.
2 Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22;983-988.
3 Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114:e257-e354.
4 Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946-952.
AF Stat™: A Call to Action for Atrial Fibrillation is an initiative sponsored by sanofi-aventis U.S. LLC.
More information about AF Stat: